BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23146921)

  • 1. Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas.
    Kaur S; Baine MJ; Guha S; Ochi N; Chakraborty S; Mallya K; Thomas C; Crook J; Wallace MB; Woodward TA; Jain M; Singh S; Sasson AR; Skinner V; Raimondo M; Batra SK
    Pancreas; 2013 Apr; 42(3):494-501. PubMed ID: 23146921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer.
    Kaur S; Chakraborty S; Baine MJ; Mallya K; Smith LM; Sasson A; Brand R; Guha S; Jain M; Wittel U; Singh SK; Batra SK
    PLoS One; 2013; 8(2):e55171. PubMed ID: 23383312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA; Horneffer-van der Sluis VM; Wadsworth CA; Laird F; Gierula M; Thillainayagam AV; Vlavianos P; Westaby D; Taylor-Robinson SD; Edwards RJ; Khan SA
    Am J Gastroenterol; 2011 Sep; 106(9):1711-7. PubMed ID: 21670771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin.
    Budzynska A; Nowakowska-Dulawa E; Marek T; Boldys H; Nowak A; Hartleb M
    J Physiol Pharmacol; 2013 Feb; 64(1):109-14. PubMed ID: 23568978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report.
    Hogendorf P; Durczyński A; Skulimowski A; Kumor A; Poznańska G; Strzelczyk J
    Cancer Biomark; 2016 Mar; 16(4):537-43. PubMed ID: 27002756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.
    El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
    Pancreas; 2013 Jan; 42(1):149-54. PubMed ID: 22617715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer.
    Levink IJM; Visser IJ; Koopmann BDM; van Driel LMJW; Poley JW; Cahen DL; Bruno MJ; Fuhler GM
    Gastrointest Endosc; 2022 Nov; 96(5):801-813.e2. PubMed ID: 35537661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
    Koopmann J; Buckhaults P; Brown DA; Zahurak ML; Sato N; Fukushima N; Sokoll LJ; Chan DW; Yeo CJ; Hruban RH; Breit SN; Kinzler KW; Vogelstein B; Goggins M
    Clin Cancer Res; 2004 Apr; 10(7):2386-92. PubMed ID: 15073115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test.
    Wang HJ; He XJ; Ma YY; Jiang XT; Xia YJ; Ye ZY; Zhao ZS; Tao HQ
    Anat Rec (Hoboken); 2010 Nov; 293(11):1855-63. PubMed ID: 20730863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia.
    Moniaux N; Chakraborty S; Yalniz M; Gonzalez J; Shostrom VK; Standop J; Lele SM; Ouellette M; Pour PM; Sasson AR; Brand RE; Hollingsworth MA; Jain M; Batra SK
    Br J Cancer; 2008 May; 98(9):1540-7. PubMed ID: 18392050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.
    Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK
    Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of serum and diagnostic peritoneal lavage concentration of matrix metalloproteinase-2, matrix metalloproteinase-9, carbohydrate antigen 19-9, and carcinoembryonic antigen in patients with pancreatic cancer and chronic pancreatitis.
    Dranka-Bojarowska D; Lewinski A; Lekstan A; Gajda M; Ciosek J; Mrowiec S
    J Physiol Pharmacol; 2020 Oct; 71(5):. PubMed ID: 33571962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?
    Schmidt-Ott KM
    Nephrol Dial Transplant; 2011 Mar; 26(3):762-4. PubMed ID: 21310736
    [No Abstract]   [Full Text] [Related]  

  • 15. Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?
    Barresi V; Di Gregorio C; Reggiani-Bonetti L; Ieni A; Ponz-De Leon M; Barresi G
    Hum Pathol; 2011 Nov; 42(11):1720-6. PubMed ID: 21420718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer.
    Kaur S; Sharma N; Krishn SR; Lakshmanan I; Rachagani S; Baine MJ; Smith LM; Lele SM; Sasson AR; Guha S; Mallya K; Anderson JM; Hollingsworth MA; Batra SK
    Clin Cancer Res; 2014 Feb; 20(3):688-700. PubMed ID: 24240113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?
    McLean MH; Thomson AJ; Murray GI; Fyfe N; Hold GL; El-Omar EM
    Br J Cancer; 2013 Jun; 108(12):2537-41. PubMed ID: 23736029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA19-9 antigen levels can distinguish between benign and malignant pancreaticobiliary disease.
    Morris-Stiff G; Teli M; Jardine N; Puntis MC
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):620-6. PubMed ID: 20007080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neutrophil gelatinase-associated lipocalin as a new diagnostic tool for acute kidney injury].
    El Housseini Y; Schmidtko J; Meier P
    Rev Med Suisse; 2013 Nov; 9(406):2101-6. PubMed ID: 24383284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.